ImageneBio/$IMA
13:30
21:10
04:45
12:25
20:00
1D1W1MYTD1Y5YMAX
About ImageneBio
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
Ticker
$IMA
Sector
Primary listing
Employees
17
Headquarters
Website
ImageneBio Metrics
BasicAdvanced
$64m
-
-$7.06
-
-
Price and volume
Market cap
$64m
52-week high
$17.96
52-week low
$3.94
Average daily volume
31k
Financial strength
Current ratio
18.391
Quick ratio
17.668
Long term debt to equity
0.089
Total debt to equity
1.959
Profitability
EBITDA (TTM)
-54.038
Effective tax rate (TTM)
0.68%
Management effectiveness
Return on assets (TTM)
-45.61%
Return on equity (TTM)
-86.15%
Valuation
Price to book
0.52
Price to tangible book (TTM)
0.52
Price to free cash flow (TTM)
-0.784
Free cash flow yield (TTM)
-127.57%
Free cash flow per share (TTM)
-7.259
Growth
Revenue change (TTM)
-100.00%
Earnings per share change (TTM)
9,996.67%
ImageneBio News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs